28 October 2021
Roche and the Zur Rose Group announce collaboration to offer innovative health journeys for people living with diabetes
Today, Roche and the Zur Rose Group announced a collaboration to empower people with diabetes and their caregivers in their daily therapy management. In Europe, there are 60 million people living with diabetes, i.e. approximately 9% of the population older than 20 years.
19 May 2021
Roche launches mySugr Pump Control within the mySugr app to simplify insulin pump therapy via smartphone
mySugr now allows control of the Accu-Chek Insight insulin pump directly via smartphone, starting in Austria, bringing more discretion and simplicity to the life of people with diabetes.
06 May 2021
Roche and Lilly will integrate data from Lilly’s connected insulin pen solution into the mySugr app in several countries. Both companies are dedicated to driving new possibilities to ease the complexity of daily decision making for people with diabetes on insulin pen therapy and their healthcare professionals.
07 April 2021
The connection of the Novo Nordisk® smart insulin pens with the mySugr Logbook is now available on iOS in the first country Sweden, with more markets to follow. Bringing data together and setting it into context provides patients and healthcare professionals with a broader picture of the individual diabetes therapy and aims to support its optimization.
01 March 2021
Roche integrates the Accu-Chek Insight insulin pump into the automated insulin delivery (AID) system from Diabeloop
The Accu-Chek Insight insulin pump from Roche will be the first pump with a pre-filled cartridge that can be operated in loop mode. As part of DBLG1 System from Diabeloop, the Accu-Chek Insight insulin pump will enable people with diabetes to better manage their diabetes and improve their time in range.